Smoking Cessation Flashcards
5 A’s
Ask about tobacco use Advise quitting Assess readiness to quit Assist to quit with pharmacotherapy Arrange follow up in 1-2 weeks
Nicotine Replacement Therapy
Multiple dosage forms available
Patches, gum, lozenge, inhalers, and nasal spray
Bupoprion SR
Zyban
Inhibits dopamine reuptake to curb cravings
BOX: Suicide risk
CONTRA: seizures, anorexia/bulimia, abrupt discontinuation of alcohol/ethanol, MAOIs
ADR: Tachy, weight loss, GI, Agitation/head issues
Nicotine
For smoking cessation
Reward effect in limbic system and stimulation in the cortex
ADR: headaches and dyspepsia (tummy pain)
Dose adjustments to protect renal and hepatic system
Nicotine patches (Nicoderm CQ)
Dosing: 21mg for more than 10 cigs a day
14 mg for 10 or fewer
7mg for titration down or tolerability issues
Daily patches. Easy, steady, OTC.
Can’t alter nicotine levels, takes 3 hours for peak effect
Nicotine Gum (Nicorette)
2mg if first cig is 30 mins or more after waking
4mg if first cig is within 30 mins of waking
1 piece every hour with no food or drink 30 mins before or after
User controlled dose, oral sensation
Unpleasant taste and oral complaints, difficult with dentures
Nicotine Lozenge (Nicorette)
2mg if first cig is 30 mins or more after waking
4mg if first cig is within 30 mins of waking
1 every 1-2 hours, no food or drink
User controlled, oral sensation, can be used with dentures
Unpleasant taste, oral complaints
Nicotine Inhaler (Nicotrol)
10mg cartridge. 1 cartridge every 1-2 hours PRN (max 16)
Deep inhale into back of throat
User controlled, oral sensation
Visible (social), caution with COPD, oral complaints
Nicotine Nasal Spray
0.5mg per spray. 1 spray to each nostril every 1-2 hours as needed (max 10/HOUR or 80/day)
User controlled, most rapid delivery of nicotine
Nasal/throat irritation
Varenicline (Chantix)
ADR: Bad dreams/sleep behavior, nausea/vomiting, depression, SEIZURES
Oral tabs, partial agonism stimulates some dopamine activity but to a much smaller degree than nicotine and decreases cravings and withdrawal symptoms
Dose adjustment in severe kidney dysfunction
Therapy Selection and Follow Up
Pt preference
2 agents for NRT initially. Patch (long acting) and a short acting for cravings
Buproprion is not recommended for initial therapy
Focus on reinforcement of quitting, address problems, encourage abstinence, weening of pharmacotherapy eventually